| Quarterly Financials | Dec 2024 | Sept 2025 | Dec 2025 |
Revenue  | 12 | 8 | 40 |
| Expenses | 7 | 6 | 12 |
| EBITDA | 5 | 1 | 28 |
| Operating Profit % | 37 % | -7 % | 69 % |
| Depreciation | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 |
| Profit Before Tax | 4 | 0 | 27 |
| Tax | 1 | -2 | 7 |
| Net Profit | 3 | 2 | 20 |
| EPS in ₹ | 0.72 | 0.05 | 0.47 |
Shukra Pharmaceuticals
Shukra Pharmaceuticals
38.88
-0.73
(-1.84%)
Market Cap
1,702.44 Cr
PE Ratio
146.70
Volume
2,04,002.00
Day High - Low
40.98 - 38.02
52W High-Low
65.26 - 11.74
Key Fundamentals
Market Cap
1,702.44 Cr
EPS
0.22
PE Ratio
146.70
PB Ratio
26.36
Book Value
1.50
EBITDA
16.90
Dividend Yield
0.03 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
15.24
Debt to Equity
0.06
Actual
Company News
View All News
Shukra Pharmaceuticals reports exceptional Q3FY26 performance with net profit jumping 543% to ₹2,036.46 lakhs and revenue growing 270% YoY. Nine-month profits soar 467% to ₹2,377.46 lakhs.
Shukra Pharmaceuticals allots 46,43,000 convertible equity warrants to promoters at ₹34 per warrant, raising ₹3.95 crore upfront with potential total of ₹15.79 crore.
Shukra Pharmaceuticals' postal ballot for continuing independent director Jitendra Shah beyond 75 years approved with overwhelming 99.99% support through remote e-voting process.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,704.40 | #1 4,08,942.65 | 37.30 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 55.54 | |
6,054.50 | 1,60,727.95 | 66.33 | 9,712.00 | 18.67 | 2,191 | 35.10 | 43.09 | |
4,023.50 | 1,36,173.52 | 63.99 | 11,539.40 | 6.99 | 1,911 | 30.46 | 57.08 | |
1,326.70 | 1,07,167.08 | 23.56 | 28,409.50 | 7.12 | 5,291 | -57.18 | 29.53 | |
1,240.20 | 1,03,510.86 | 18.66 | 33,741.20 | 16.73 | 5,725 | -15.28 | 54.93 | |
2,195.20 | 1,00,276.47 | 22.98 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 60.38 | |
905.25 | 91,089.33 | #1 18.07 | 23,511.00 | 18.55 | 4,615 | 34.60 | 53.85 | |
2,089.30 | 86,247.36 | 50.17 | 12,744.20 | #1 20.90 | 2,007 | 7.65 | 43.88 | |
1,212.70 | 70,433.81 | 20.82 | 32,345.60 | 9.43 | 3,484 | 3.81 | 56.90 | |
5,653.50 | 67,596.07 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 48.17 |
Growth Rate
Revenue Growth
-52.45 %
Net Income Growth
-48.11 %
Cash Flow Change
252.31 %
ROE
-52.61 %
ROCE
-36.69 %
EBITDA Margin (Avg.)
60.33 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 18 | 17 | 19 | 24 | 28 | 34 | 36 | 35 | 75 | 78 | 87 |
| Fixed Assets | 10 | 10 | 10 | 14 | 16 | 17 | 18 | 18 | 20 | 20 | 19 |
| Current Assets | 7 | 6 | 7 | 8 | 11 | 15 | 16 | 16 | 53 | 56 | 65 |
| Capital Work in Progress | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 7 | 6 | 7 | 8 | 11 | 15 | 16 | 16 | 53 | 56 | 65 |
| Total Liabilities | 18 | 17 | 19 | 24 | 28 | 34 | 36 | 35 | 75 | 78 | 87 |
| Current Liabilities | 1 | 1 | 2 | 3 | 4 | 7 | 7 | 12 | 43 | 14 | 17 |
| Non Current Liabilities | 4 | 3 | 3 | 6 | 9 | 11 | 13 | 6 | 7 | 6 | 7 |
| Total Equity | 14 | 14 | 15 | 15 | 15 | 15 | 16 | 16 | 25 | 58 | 63 |
| Reserve & Surplus | 12 | 13 | 13 | 13 | 14 | 14 | 14 | 15 | 21 | 47 | 19 |
| Share Capital | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 11 | 44 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 1 | -1 | -1 | 0 | -0 | 0 | -0 | 4 | 6 | 2 |
| Investing Activities | 1 | -0 | -1 | -5 | -3 | -3 | -2 | -2 | -4 | -1 | -1 |
| Operating Activities | -2 | 3 | -0 | 1 | 0 | 1 | 1 | 8 | 3 | -5 | 8 |
| Financing Activities | 1 | -1 | 0 | 4 | 2 | 2 | 2 | -7 | 5 | 12 | -5 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Aug 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 49.17 % | 49.17 % | 49.17 % | 49.17 % | 49.17 % | 49.17 % | 49.17 % | 49.17 % | 50.90 % | 50.90 % | 50.90 % | 50.90 % | 50.96 % | 50.96 % | 50.96 % | 50.96 % | 50.96 % | 50.96 % | 50.96 % | 50.96 % | 50.96 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.80 % | 0.80 % | 0.80 % | 0.80 % | 0.80 % | 0.80 % | 0.80 % | 0.80 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 33.02 % | 33.02 % | 32.90 % | 32.86 % | 32.83 % | 32.81 % | 33.00 % | 33.06 % | 29.14 % | 29.10 % | 29.11 % | 29.14 % | 28.94 % | 9.79 % | 9.19 % | 9.25 % | 9.41 % | 9.29 % | 28.69 % | 9.20 % | 9.43 % |
| Others | 17.01 % | 17.01 % | 17.14 % | 17.18 % | 17.21 % | 17.22 % | 17.04 % | 16.98 % | 19.85 % | 19.88 % | 19.88 % | 19.85 % | 19.99 % | 39.14 % | 39.73 % | 39.68 % | 39.51 % | 39.64 % | 20.24 % | 39.72 % | 39.50 % |
| No of Share Holders | 9,345 | 9,345 | 9,305 | 9,268 | 9,239 | 9,193 | 9,237 | 9,234 | 9,544 | 9,582 | 9,600 | 9,747 | 10,963 | 12,974 | 14,989 | 16,321 | 17,844 | 18,231 | 20,337 | 21,441 | 25,649 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.5 | 0.5 | 0.5 | 0.00 | 0.00 | 0.5 | 0.5 | 1 | 0.01 | 0.00 |
| Dividend Yield (%) | 156.25 | 263.16 | 208.33 | 0.00 | 0.00 | 42.74 | 6.13 | 4.58 | 0.03 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 04 Feb 2026 |  Quarterly Result Announcement | NA | 04 Feb 2026 | 42.64 | 39.61 |
| 19 Oct 2016 |  Change Of Name | NA | 19 Oct 2016 | 0.33 | 0.33 |
| 22 Sept 2022 |  Dividend | ₹ 0.50 /share | 22 Sept 2022 | 0.30 | 1.06 |
| 02 Feb 2023 |  Rights | 6:1 | 02 Feb 2023 | 0.84 | 1.37 |
| 16 Sept 2023 | Dividend | ₹ 0.50 /share | 15 Sept 2023 | 2.58 | 4.56 |
| 20 Apr 2024 |  Bonus | 3:1 | 19 Apr 2024 | 7.53 | 8.48 |
| 23 Aug 2024 |  Extraordinary General Meeting | NA | 23 Aug 2024 | 9.01 | 6.14 |
| 24 Sept 2024 | Dividend | ₹ 1.00 /share | 23 Sept 2024 | 10.69 | 6.36 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 6.39 | 6.75 |
| 14 Nov 2024 | Quarterly Result Announcement | NA | 14 Nov 2024 | 6.93 | 6.49 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 23.34 | 21.09 |
| 29 Jan 2025 |  Split | 1:10 | 21 Mar 2025 | 22.45 | 22.45 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 13.98 | 13.27 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 20.70 | 18.68 |
| 18 Sept 2025 | Dividend | ₹ 0.01 /share | 18 Sept 2025 | 13.26 | 30.04 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 26.22 | 35.16 |
| 01 Nov 2025 | Extraordinary General Meeting | NA | 01 Nov 2025 | 34.45 | 41.01 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 41.84 | 41.77 |
Announcements
Unaudited Financial Results For The Quarter Ended December 2025
3 hrs ago
3 hrs agoBoard Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday February 04 20263 hrs ago
3 hrs agoUpdate on board meeting5 days ago
5 days agoBoard Meeting Intimation for Unaudited Financial Result For The Third Quarter Ended On 31 December 2025 Along With The Auditors Limited Review Report.5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Allotment6 days ago
6 days agoBoard Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Today6 days ago
6 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Jan 07, 2026Voting Result Along With Scrutinizer Report Of Postal BallotJan 05, 2026
Jan 05, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJan 05, 2026
Jan 05, 2026Reconstitution Of Committees Of The Company.Dec 30, 2025
Dec 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 30, 2025
Dec 30, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 30, 2025
Dec 30, 2025Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On December 30 2025.Dec 30, 2025
Dec 30, 2025Closure of Trading WindowDec 23, 2025
Dec 23, 2025Intimation For Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations Working In The Government Market Of Gujarat For Our Laparoscopic Sets And Accessories.Dec 22, 2025
Dec 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 05, 2025
Dec 05, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderDec 03, 2025
Dec 03, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 03, 2025
Dec 03, 2025Approval Of Continuation Of Directorship Of Mr. Jitendra Somchand Shah Non-Executive Independent Director Who Has Attained Age Of 75 Years On September 22 2025 Subject To Approval Of Shareholders.Nov 29, 2025
Nov 29, 2025Outcome Of The Meeting Of The Board Of Directors Held On Saturday November 29 2025Nov 29, 2025
Nov 29, 2025Board Meeting Outcome for Outcome Of The Meetins Of The Board Of Directors Held On Saturdav. November
29.2025.Nov 29, 2025
Nov 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Nov 14, 2025Un-Audited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30 2025 Along With The Auditors Limited Review Reports In Accordance With The Provisions Of Regulation 33 Of The SEBI Listing Regulations.Nov 13, 2025
Nov 13, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On November 13 2025.Nov 13, 2025
Nov 13, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Incorporation Of Subsidiary Company.Nov 10, 2025
Nov 10, 2025Voting Result Along With Scrutinizer Report Of Extra Ordinary General Meeting (EOGM) Of The Company Held On November 01 2025.Nov 01, 2025
Nov 01, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMNov 01, 2025
Nov 01, 2025Board Meeting Intimation for Unaudited Financial Result For The Half Year Ended On 30TH September 2025 Along With The Auditors Limited Review Report.Oct 31, 2025
Oct 31, 2025Receipt Of Distributorship RightsOct 31, 2025
Oct 31, 2025Intimation U/R 30 Of SEBI LODR- Incorporation Of Subsidiary CompanyOct 24, 2025
Oct 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 15, 2025
Oct 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Authorization Received From Meril Healthcare Private Limited For The Project Of ROBOTIC ASSISTED SURGERY SYSTEM FOR ORTHOPEDICS At Directorate General Armed Forces Medical Services And INHS Asvini Maharashtra.Oct 08, 2025
Oct 08, 2025Notice Of Extra Ordinary General Meeting Of Shukra Pharmaceuticals Limited To Be Held On Saturday November 01 2025.Oct 07, 2025
Oct 07, 2025Board Meeting Outcome for Revised Outcome Of The Meeting Of The Board Of Directors Held On Friday October 03 2025.Oct 04, 2025
Oct 04, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesOct 03, 2025
Oct 03, 2025Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Friday October 03 2025.Oct 03, 2025
Oct 03, 2025Voting Result Along With Scrutinizer Report Of 32Nd Annual General Meeting (AGM) Of The Company Held On September 30 2025.Oct 03, 2025
Oct 03, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 29, 2025
Sep 29, 2025Board Meeting Intimation for Preferential Issue Of Warrants As Per Chapter V And In Accordance With Securities And Exchange Board Of India (Issue Of Capital And Disclosure Requirements) Regulations 2018 To Promoters Subject To Approval Of Shareholders.Sep 22, 2025
Sep 22, 2025Intimation Of Book Closure And Record Date Pursuant To Regulation 42 Of SEBI Listing Regulations For Annual General Meeting Of The Company.Sep 12, 2025
Sep 12, 2025Intimation Of Record Date For Final Dividend For Financial Year 2024-2025.Sep 12, 2025
Sep 12, 2025Corrigendum To The Notice Of 32ND Annual General Meeting And Annual Report (2024-25) Of The CompanySep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2025
Sep 10, 2025Announcement Under Regulation 30 Of SEBI (LODR)- Strategic PAN India Distribution Tie-UpSep 10, 2025
Sep 10, 2025Reg. 34 (1) Annual Report.Sep 08, 2025
Sep 08, 2025Submission Of Notice Of 32Nd AGM Of The Companny.Sep 08, 2025
Sep 08, 2025Board Meeting Outcome for Outcome Of The Board Of Directors Of The Company.Sep 08, 2025
Sep 08, 2025Appointment Of Secretarial Auditor Of The Company Subject To Approval From The Members Of The Company.Aug 30, 2025
Aug 30, 2025Technical Indicators
RSI(14)
Neutral 33.33
ATR(14)
Less Volatile 3.15
STOCH(9,6)
Oversold 9.17
STOCH RSI(14)
Oversold 3.77
MACD(12,26)
Bearish -1.20
ADX(14)
Strong Trend 25.84
UO(9)
Bearish 43.35
ROC(12)
Downtrend And Accelerating -26.04
WillR(14)
Oversold -99.83
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
